Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
The markets have been hot these past six months. The pace of inflation is cooling off, the Federal Reserve is expected to dial back its own pace of interest rate hikes, tech stocks are booming on the strength of AI, and in all, the S&P gave five consecutive months of gains through the end of July. But did we just see a black swan? Fitch cut the US government’s credit rating yesterday, from AAA to AA+, saying that the Federal government’s fiscal situation is likely to deteriorate significantly ov
Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.
Radiopharm Theranostics Ltd (ASX:RAD) has been initiated coverage by Jones Research with a buy rating and a price target of A$0.75. Jones Research notes.